Are popular alternative medicines a risk to cancer patients?

Are popular alternative medicines a risk to cancer patients?

3 Dec 2014

New research shows that the 10 most commonly asked complementary medicines interact with conventional cancer treatments, and this may be dangerous for patients. Therefore, discussing such medicines with healthcare providers is very important.

The new research was presented at the Clinical Oncology Society of Australia's (COSA's) Annual Scientific Meeting. It reveals that the 10 most commonly inquired about complementary medicines at Melbourne's Peter MacCallum Cancer Centre all have predicted or actual drug interactions when taken with chemotherapy, radiation therapy or before surgery. The research involved an audit of inquiries to the hospital's Medicines Information Centre from health providers and patients, over 2 years.


What are the 10 products/supplements?

The 10 most commonly inquired about products or supplements (excluding vitamins and minerals) were:

  • fish oil
  • turmeric
  • coenzyme Q10
  • milk thistle
  • green tea
  • ginger
  • lactobacillus
  • licorice
  • astragalus and
  • reishi mushroom.

Lead researcher: some products may increase or decrease effects of chemotherapy

Lead researcher and Senior Pharmacist at Peter MacCallum's Medicines Information Centre, Sally Brooks, said while levels of these substances found in a healthy diet were unlikely to cause contraindications, larger amounts in complementary medicines could: "These products may increase the effects of chemotherapy and put the patient at risk of toxicity, or decrease the efficacy of chemotherapy. Those that contain high levels of anti-oxidants may interfere with both chemotherapy and radiation therapy."

Ms Brooks said more research was needed. "Every cancer type is different and every individual case is different. What's safe for one person may not be for another. In the meantime, we need to raise public awareness of proven and potential risks."

"It's best to err on the side of caution"

COSA President, Associate Professor Sandro Porceddu, said patients could wrongly assume anything 'complementary' must 'complement' conventional cancer therapies and anything natural must be safe. "Although some complementary therapies and medicines may benefit patients, they can also be dangerous and undermine treatment," he said.

"Until we know more, it's best to err on the side of caution and for patients to discuss with their healthcare provider any complementary or alternative therapies they are using or considering using, in order to minimize risk."


Source: Medical News Today

Login to your account

Did you forget your password?